| Name | LOXO-195 |
|---|---|
| Synonyms |
Selitrectinib Racemate
LOXO195 R racemic 12H-15,17-Ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one, 5-fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-, (3) LOXO-195(3) LOXO-195, 10 mM in DMSO Selitrectinib(LOXO-195) Racemate (6RS)-LOXO-195 (18bR)-17-Fluoro-1,2,3,11,12,13,14,18b-octahydro-12-methyl-10H-5,7-ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-10-one |
| Description | (3aR)-Selitrectinib ((3aR)-LOXO-195) is an isform of Selitrectinib (HY-101977), which is a next-generation TRK kinase inhibitor, with IC50s of 0.6 nM and <2.5 nM for TRKA and TRKC, respectively[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C20H21FN6O |
|---|---|
| Molecular Weight | 380.4 |
| Exact Mass | 380.17608748 |